speb/financial-data huggingface dataset:
Financial ratios for ASAN — quarterly report dated 2025-01-31
Total revenue: 188334000
Gross profit: 168730000
Operating income: -63589000
Net income: -62299000
Capital expenditures: 1505000
Operating cash flow: 15855000
Depreciation & amortization: 4813000
Net tangible assets: 227523000
Owner earnings: -58991000
Return on net tangible assets (%): -25.92748864949917
Buffett classification: The Gruesome
Stock price: 21.34
Shares outstanding: 167823036
Book value: 227523000
P/B ratio: 15.740578263472264
Market cap (USD): 3581343588.24
Debt to equity: 1.1563226574895724
Current ratio: 1.4447244821640288
Quick ratio: 1.4447244821640288
Interest coverage ratio: -74.6349765258216
COGS to revenue (%): 10.409166693215246
R&D to revenue (%): 44.72851423534784
SG&A to revenue (%): 78.62627034948548
Free cash flow (dilution-adjusted): -38230000
Buyback yield (%): 0.1252323294175773
Retained earnings: -1828476000
Receivables turnover: 2.150741717770393
Capitalized R&D asset: 84239000
ROCI (R&D-adjusted, %): -1.327112475000164
FCF margin (%): -20.299043189227646
Rule of 40 score: -20.299043189227646
Financial ratios for ASAN — quarterly report dated 2025-04-30
Total revenue: 187267000
Gross profit: 168040000
Operating income: -43904000
Net income: -40018000
Capital expenditures: 638000
Operating cash flow: 6764000
Depreciation & amortization: 4963000
Net tangible assets: 236304000
Owner earnings: -35693000
Return on net tangible assets (%): -15.10469564628614
Buffett classification: The Gruesome
Stock price: 16.14
Shares outstanding: 167823036
Book value: 236304000
P/B ratio: 11.462623574040219
Market cap (USD): 2708663801.04
Debt to equity: 1.0971164262983275
Current ratio: 1.473586686798727
Quick ratio: 1.473586686798727
Interest coverage ratio: -55.50442477876106
COGS to revenue (%): 10.26715865582297
R&D to revenue (%): 40.11758612035222
SG&A to revenue (%): 73.05985571403397
Free cash flow (dilution-adjusted): -44172000
Buyback yield (%): 0.5362791792182808
Retained earnings: -1884100000
Receivables turnover: 2.7508519889535226
Capitalized R&D asset: 131567130
ROCI (R&D-adjusted, %): -3.5939053968367234
Rosenberg metric: -0.008190980424743883
FCF margin (%): -23.587711663026585
Revenue growth (%): -0.566546667091444
Rule of 40 score: -24.15425833011803
Financial ratios for ASAN — quarterly report dated 2025-07-31
Total revenue: 196936000
Gross profit: 176715000
Operating income: -49456000
Net income: -48360000
Capital expenditures: 1297000
Operating cash flow: 39835000
Depreciation & amortization: 5146000
Net tangible assets: 224556000
Owner earnings: -44511000
Return on net tangible assets (%): -19.821781649120933
Buffett classification: The Gruesome
Stock price: 14.68
Shares outstanding: 167823036
Book value: 224556000
P/B ratio: 10.971170525303265
Market cap (USD): 2463642168.48
Debt to equity: 1.123728602219491
Current ratio: 1.4113096052178589
Quick ratio: 1.4113096052178589
Interest coverage ratio: -62.05269761606023
COGS to revenue (%): 10.267802737945322
R&D to revenue (%): 40.305479952878095
SG&A to revenue (%): 74.53944428646871
Free cash flow (dilution-adjusted): -26772000
Buyback yield (%): 1.1719234379647445
Retained earnings: -1960252000
Receivables turnover: 2.844580540790386
Capitalized R&D asset: 157509960
ROCI (R&D-adjusted, %): -8.054148233954113
Rosenberg metric: 0.11547113554381248
FCF margin (%): -13.594264126416705
Revenue growth (%): 5.163216156610615
Rule of 40 score: -8.431047969806091
Financial ratios for ASAN — quarterly report dated 2025-10-31
Total revenue: 201033000
Gross profit: 178726000
Operating income: -69986000
Net income: -68433000
Capital expenditures: 669000
Operating cash flow: 16172000
Depreciation & amortization: 5809000
Net tangible assets: 188362000
Owner earnings: -63293000
Return on net tangible assets (%): -33.601788046421255
Buffett classification: The Gruesome
Stock price: 14.05
Shares outstanding: 167823036
Book value: 188362000
P/B ratio: 12.517990124335057
Market cap (USD): 2357913655.8
Debt to equity: 1.3270404858729468
Current ratio: 1.3954630868019013
Quick ratio: 1.3954630868019013
Interest coverage ratio: -91.2464146023468
COGS to revenue (%): 11.096188188008933
R&D to revenue (%): 36.71685743136699
SG&A to revenue (%): 87.00014425492331
Free cash flow (dilution-adjusted): -41317000
Buyback yield (%): 1.305603363561469
Retained earnings: -2059470000
Receivables turnover: 2.780693261037955
Capitalized R&D asset: 151786830
ROCI (R&D-adjusted, %): -12.652223089276976
Rosenberg metric: 0.025335113888328965
FCF margin (%): -20.552347127088588
Revenue growth (%): 2.080371288134216
Rule of 40 score: -18.47197583895437
Financial ratios for ASAN — quarterly report dated 2026-01-31
Total revenue: 205570000
Gross profit: 180566000
Operating income: -33985000
Net income: -32213000
Capital expenditures: 1188000
Operating cash flow: 27590000
Depreciation & amortization: 6119000
Net tangible assets: 154117000
Owner earnings: -27282000
Return on net tangible assets (%): -17.70213539064477
Buffett classification: The Gruesome
Stock price: 10.25
Shares outstanding: 167823036
Book value: 154117000
P/B ratio: 11.161559847388672
Market cap (USD): 1720186119
Debt to equity: 1.6183678633765257
Current ratio: 1.1842800686599337
Quick ratio: 1.1842800686599337
Interest coverage ratio: -42.8562421185372
COGS to revenue (%): 12.163253393004817
R&D to revenue (%): 35.598579559274214
SG&A to revenue (%): 68.770248577127
Free cash flow (dilution-adjusted): -25600000
Buyback yield (%): 3.373065237483177
Retained earnings: -2149706000
Receivables turnover: 1.863532525926463
Capitalized R&D asset: 148828790
ROCI (R&D-adjusted, %): -7.371736118329483
Rosenberg metric: 0.02492785823635403
FCF margin (%): -12.453178965802403
Revenue growth (%): 2.2568434038192735
Rule of 40 score: -10.19633556198313
Financial ratios for ASAN — annual report dated 2026-01-31
Total revenue: 790806000
Gross profit: 704047000
Operating income: -197331000
Net income: -189024000
Capital expenditures: 3792000
Operating cash flow: 90361000
Depreciation & amortization: 22037000
Net tangible assets: 154117000
Owner earnings: -170779000
Return on net tangible assets (%): -110.81126676486046
Buffett classification: The Gruesome
Stock price: 10.25
Shares outstanding: 167823036
Book value: 154117000
P/B ratio: 11.161559847388672
Market cap (USD): 1720186119
Debt to equity: 1.6183678633765257
Current ratio: 1.1842800686599337
Quick ratio: 1.1842800686599337
Interest coverage ratio: -62.68456162642948
COGS to revenue (%): 10.970958743358041
R&D to revenue (%): 38.12515332458277
SG&A to revenue (%): 75.85703699769603
Free cash flow (dilution-adjusted): -137861000
Buyback yield (%): 7.6855637038191915
Retained earnings: -2149706000
Receivables turnover: 7.168812096598738
Capitalized R&D asset: 637425930
ROCI (R&D-adjusted, %): -22.272991871895965
Rosenberg metric: 0.16799280750409262
FCF margin (%): -17.432973447343596
Revenue growth (%): 9.246058717238864
Rule of 40 score: -8.186914730104732
Financial ratios for ATS.TO — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.08
Shares outstanding: 97007132
Market cap (USD): 3500017322.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATS.TO — annual report dated 2023-03-31
Total revenue: 1909173333.3333333
Gross profit: 537637037.037037
Operating income: 185167407.4074074
Net income: 94593333.33333333
Capital expenditures: 40477037.03703704
Operating cash flow: 94666666.66666666
Depreciation & amortization: 92954814.8148148
Net tangible assets: -433054814.8148148
Owner earnings: 147071111.11111107
Return on net tangible assets (%): -33.96131530693231
Capex to operating income (%): 21.85969853105898
Buffett classification: The Great
Stock price: 41.91851851851852
P/E ratio: 42.98818020125136
Shares outstanding: 97007132
Book value: 837468888.8888886
P/B ratio: 4.85557769741806
Market cap (USD): 4066395259.17037
Debt to equity: 1.1134600467192592
Current ratio: 1.391351426975261
Quick ratio: 1.1452100527898914
Effective tax rate (%): 20.07247873518974
Interest coverage ratio: 3.8648711328251832
COGS to revenue (%): 71.83927579281938
SG&A to revenue (%): 15.278010571959785
Free cash flow (dilution-adjusted): 31419259.25925926
Buyback yield (%): 0.6090752577864376
Retained earnings: 393116296.2962963
Inventory turnover: 7.208326520442565
Receivables turnover: 2.696826443167907
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.99815216408783
FCF margin (%): 1.6456996706738307
Rule of 40 score: 1.6456996706738307
Financial ratios for ATS.TO — annual report dated 2024-03-31
Total revenue: 2246580000
Gross profit: 633706666.6666666
Operating income: 250504444.44444442
Net income: 143837777.77777776
Capital expenditures: 26384444.444444444
Operating cash flow: 15392592.592592591
Depreciation & amortization: 104573333.33333333
Net tangible assets: -168504444.44444445
Owner earnings: 222026666.66666666
Return on net tangible assets (%): -131.76309230221423
Capex to operating income (%): 10.53252548191649
Buffett classification: The Great
Stock price: 33.514705882352935
P/E ratio: 22.603001434668137
Shares outstanding: 97007132
Book value: 1247368148.1481483
P/B ratio: 2.606420167371831
Market cap (USD): 3251165497.4705877
Debt to equity: 0.7645199047238421
Current ratio: 1.703924081503368
Quick ratio: 1.4164411698692878
Effective tax rate (%): 21.2844616862664
Interest coverage ratio: 4.784474343194262
COGS to revenue (%): 71.79238368245659
SG&A to revenue (%): 14.232101930737187
Free cash flow (dilution-adjusted): -58467407.4074074
Buyback yield (%): 0.5430303326161122
Retained earnings: 536662962.9629629
Inventory turnover: 7.35899351088279
Receivables turnover: 2.5088889899946647
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.053147643965367
FCF margin (%): -2.602507251351272
Revenue growth (%): 17.672919518395403
Rule of 40 score: 15.070412267044132
Financial ratios for ATS.TO — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 29.066666666666666
Shares outstanding: 97007132
Market cap (USD): 2819673970.133333
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATS.TO — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 30.65734265734266
Shares outstanding: 97007132
Market cap (USD): 2973980885.9300704
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ATS.TO — annual report dated 2025-03-31
Total revenue: 1771530069.93007
Gross profit: 452200699.3006993
Operating income: 23236363.636363637
Net income: -19565034.965034965
Capital expenditures: 19874125.874125876
Operating cash flow: 18021678.32167832
Depreciation & amortization: 106762237.76223777
Net tangible assets: -312818181.8181818
Owner earnings: 67323076.92307693
Capex to operating income (%): 85.53027567112075
Buffett classification: The Gruesome
Stock price: 25.083916083916083
Shares outstanding: 97007132
Book value: 1195354545.4545455
P/B ratio: 2.035646049853834
Market cap (USD): 2433318758.6293707
Debt to equity: 0.994726087060807
Current ratio: 1.6929522150942726
Quick ratio: 1.408471202885931
Interest coverage ratio: 0.33822257056482397
COGS to revenue (%): 74.47400374533018
SG&A to revenue (%): 20.76096361724368
Free cash flow (dilution-adjusted): -43932167.832167834
Buyback yield (%): 1.714915913970752
Retained earnings: 461795804.19580424
Inventory turnover: 5.892585860100196
Receivables turnover: 1.979881439451667
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9503456686454571
FCF margin (%): -2.479899640309353
Revenue growth (%): -21.145471341769714
Rule of 40 score: -23.625370982079065
Financial ratios for ATS.TO — quarterly report dated 2025-03-31
Total revenue: 401569230.7692308
Gross profit: 43213986.013986014
Operating income: -76958041.95804197
Net income: -48152447.55244756
Capital expenditures: 5205594.405594406
Operating cash flow: 27500699.3006993
Depreciation & amortization: 26601398.601398602
Net tangible assets: -312818181.8181818
Owner earnings: -26756643.35664336
Buffett classification: The Gruesome
Stock price: 25.083916083916083
Shares outstanding: 97007132
Book value: 1195354545.4545455
P/B ratio: 2.035646049853834
Market cap (USD): 2433318758.6293707
Debt to equity: 0.994726087060807
Current ratio: 1.6929522150942726
Quick ratio: 1.408471202885931
Interest coverage ratio: -4.011299435028249
COGS to revenue (%): 89.23872082250752
SG&A to revenue (%): 14.690967602621882
Free cash flow (dilution-adjusted): 6840559.44055944
Buyback yield (%): 0
Retained earnings: 461795804.19580424
Inventory turnover: 1.6005397099059258
Receivables turnover: 0.4487981774344185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.147512364103544
FCF margin (%): 1.7034570670307396
Rule of 40 score: 1.7034570670307396
Financial ratios for ATS.TO — quarterly report dated 2025-06-30
Total revenue: 537751824.8175182
Gross profit: 160474452.5547445
Operating income: 43997080.2919708
Net income: 17712408.759124085
Capital expenditures: 5111678.832116788
Operating cash flow: 113709489.05109487
Depreciation & amortization: 27236496.35036496
Net tangible assets: -299183211.6788321
Owner earnings: 39837226.277372256
Return on net tangible assets (%): -13.3153281074263
Capex to operating income (%): 11.61822284159533
Buffett classification: The Great
Stock price: 31.700729927007295
P/E ratio: 43.40455516731229
Shares outstanding: 97007132
Book value: 1247459854.0145986
P/B ratio: 2.465167021310458
Market cap (USD): 3075196892.525547
Debt to equity: 0.8889732127184
Current ratio: 1.6155862167330708
Quick ratio: 1.3242663493785296
Effective tax rate (%): 24.50376454483231
Interest coverage ratio: 2.338363657524149
COGS to revenue (%): 70.15826908459115
SG&A to revenue (%): 21.6600608100771
Free cash flow (dilution-adjusted): 98629927.00729927
Buyback yield (%): 0.23735943837397921
Retained earnings: 492390510.94890505
Inventory turnover: 1.664857517417759
Receivables turnover: 0.6573842403389358
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8031045490129678
FCF margin (%): 18.341160820936043
Revenue growth (%): 33.91260674714077
Rule of 40 score: 52.25376756807681
Financial ratios for ATS.TO — quarterly report dated 2025-09-30
Total revenue: 524069064.7482015
Gross profit: 156744604.31654677
Operating income: 54131654.676258996
Net income: 24229496.4028777
Capital expenditures: 5828057.553956835
Operating cash flow: 20497122.302158274
Depreciation & amortization: 28367625.899280578
Net tangible assets: -270138129.4964029
Owner earnings: 46769064.748201445
Return on net tangible assets (%): -17.31301865286078
Capex to operating income (%): 10.766450035219224
Buffett classification: The Great
Stock price: 26.194244604316545
P/E ratio: 26.218338401674632
Shares outstanding: 97007132
Book value: 1274120863.3093529
P/B ratio: 1.9943386982701565
Market cap (USD): 2541028543.971223
Debt to equity: 0.8670292056365001
Current ratio: 1.6297226487567722
Quick ratio: 1.3375920972893667
Effective tax rate (%): 33.82254574070431
Interest coverage ratio: 3.063515329180408
COGS to revenue (%): 70.09084968755835
SG&A to revenue (%): 19.58004326960036
Free cash flow (dilution-adjusted): 9797122.302158274
Buyback yield (%): 0.27225139315826347
Retained earnings: 509535251.7985612
Inventory turnover: 1.592738514137406
Receivables turnover: 0.6229804294505811
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.2115964273736752
FCF margin (%): 1.869433431806451
Revenue growth (%): -2.5444376825610733
Rule of 40 score: -0.6750042507546223
Financial ratios for ATS.TO — quarterly report dated 2025-12-31
Total revenue: 555221167.8832116
Gross profit: 164140875.91240874
Operating income: 46119708.029197074
Net income: 21921897.810218975
Capital expenditures: 4520437.956204379
Operating cash flow: 83655474.45255473
Depreciation & amortization: 29418978.10218978
Net tangible assets: -236187591.2408759
Owner earnings: 46820437.95620438
Return on net tangible assets (%): -19.82341142911888
Capex to operating income (%): 9.801532033426184
Buffett classification: The Great
Stock price: 27.5985401459854
P/E ratio: 170.40256269548206
Shares outstanding: 97007132
Book value: 1300391240.8759124
P/B ratio: 2.0588074902331472
Market cap (USD): 2677255226.948905
Debt to equity: 0.8409024572054676
Current ratio: 1.651835009298788
Quick ratio: 1.3714738305546155
Effective tax rate (%): 10.730315370210743
Interest coverage ratio: 2.604129744879034
COGS to revenue (%): 70.4368483395188
SG&A to revenue (%): 21.256604522693003
Free cash flow (dilution-adjusted): 69520437.95620437
Buyback yield (%): 0
Retained earnings: 538832116.7883211
Inventory turnover: 1.7387776825817174
Receivables turnover: 0.6519813933395562
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.8672912249074611
FCF margin (%): 12.521215324201707
Revenue growth (%): 5.9442743772669955
Rule of 40 score: 18.4654897014687
Financial ratios for AVM.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.24637681159420294
Shares outstanding: 478809370
Market cap (USD): 117967525.942029
Buyback yield (%): 0.04597064687892018
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AVM.AX — annual report dated 2022-12-31
Operating income: -939469.5945945946
Net income: -942236.4864864865
Capital expenditures: 466337.1621621622
Net tangible assets: 3820073.6486486485
Owner earnings: -1408573.6486486488
Return on net tangible assets (%): -36.87294482259345
Buffett classification: The Gruesome
Stock price: 0.13513513513513514
Shares outstanding: 478809370
Book value: 3691587.1621621624
P/B ratio: 17.52741194414107
Market cap (USD): 64703968.91891892
Debt to equity: 0
Current ratio: 5.866802869717755
Quick ratio: 5.866802869717755
Free cash flow (dilution-adjusted): -1289706.0810810812
Buyback yield (%): 0.06631031468745066
Retained earnings: -9175760.810810812
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -25.448934383127153
Rule of 40 score: 0
Financial ratios for AVM.AX — annual report dated 2023-12-31
Operating income: -501376.0273972603
Net income: -488635.61643835617
Capital expenditures: 591205.4794520548
Net tangible assets: 3885973.287671233
Owner earnings: -1079841.095890411
Return on net tangible assets (%): -27.788175984542928
Buffett classification: The Gruesome
Stock price: 0.0410958904109589
Shares outstanding: 478809370
Book value: 3892279.452054795
P/B ratio: 5.055417433317237
Market cap (USD): 19677097.397260275
Debt to equity: 0
Current ratio: 3.1801230754552714
Quick ratio: 3.1801230754552714
Free cash flow (dilution-adjusted): -1051813.0136986303
Buyback yield (%): 0
Retained earnings: -9790091.780821918
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -12.881295743875123
Rule of 40 score: 0
Financial ratios for AVM.AX — annual report dated 2024-12-31
Operating income: -605352.7950310558
Net income: -590477.0186335404
Capital expenditures: 1143220.4968944099
Net tangible assets: 5372099.378881987
Owner earnings: -1733697.5155279501
Return on net tangible assets (%): -32.27225323386996
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 478809370
Book value: 5372099.378881987
P/B ratio: 1.6607871704273747
Market cap (USD): 8921913.726708073
Debt to equity: 0
Current ratio: 5.784107989196473
Quick ratio: 5.784107989196473
Free cash flow (dilution-adjusted): -1665520.4968944099
Buyback yield (%): 1.4674524853179045
Retained earnings: -9454715.52795031
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -11.268458610626794
Rule of 40 score: 0
Financial ratios for AVM.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 5372099.378881987
Buffett classification: The Gruesome
Stock price: 0.018633540372670804
Shares outstanding: 478809370
Book value: 5372099.378881987
P/B ratio: 1.6607871704273747
Market cap (USD): 8921913.726708073
Debt to equity: 0
Current ratio: 5.784107989196473
Quick ratio: 5.784107989196473
Buyback yield (%): 0
Retained earnings: -9454715.52795031
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BELYS.BR — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.3522727272727275
Shares outstanding: 35943396
Market cap (USD): 120492066.13636364
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BELYS.BR — annual report dated 2022-12-31
Total revenue: 358968085.106383
Gross profit: 197389361.70212767
Operating income: 17473404.25531915
Net income: -72070212.76595744
Capital expenditures: 12529787.234042553
Operating cash flow: 29659574.468085106
Depreciation & amortization: 19880851.063829787
Net tangible assets: -18831914.893617023
Owner earnings: -64719148.93617021
Capex to operating income (%): 71.70776255707763
Buffett classification: The Good
Stock price: 1.2127659574468084
Shares outstanding: 35943396
Book value: 99353191.4893617
P/B ratio: 0.43874712437896174
Market cap (USD): 43590927.06382978
Debt to equity: 1.956334589686483
Current ratio: 1.6248487527922562
Quick ratio: 0.7385750186150409
Interest coverage ratio: 0.8477856921647567
COGS to revenue (%): 45.012002489405205
SG&A to revenue (%): 7.988916219660373
Free cash flow (dilution-adjusted): 17058510.638297874
Buyback yield (%): 0
Retained earnings: -203412765.9574468
Inventory turnover: 1.9938301587093217
Receivables turnover: 14.539382971389177
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.985634477254589
FCF margin (%): 4.752096731173873
Rule of 40 score: 4.752096731173873
Financial ratios for BELYS.BR — annual report dated 2023-12-31
Total revenue: 334353333.3333333
Gross profit: 184140000
Operating income: 14623333.333333332
Net income: -12327777.777777778
Capital expenditures: 11620000
Operating cash flow: 34503333.333333336
Depreciation & amortization: 22100000
Net tangible assets: -33931111.11111111
Owner earnings: -1847777.777777778
Capex to operating income (%): 79.46204695691817
Buffett classification: The Gruesome
Stock price: 0.7999999999999999
Shares outstanding: 35943396
Book value: 86355555.55555552
P/B ratio: 0.3329805084920227
Market cap (USD): 28754716.799999997
Debt to equity: 2.324948533196089
Current ratio: 0.5730688375223759
Quick ratio: 0.3181802662192285
Interest coverage ratio: 0.7449482085243674
COGS to revenue (%): 44.92652483400794
SG&A to revenue (%): 7.104925594347962
Free cash flow (dilution-adjusted): 21396666.666666664
Buyback yield (%): 0
Retained earnings: -224775555.55555555
Inventory turnover: 2.5870601067799535
Receivables turnover: 13.804844481145059
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.740341771532098
FCF margin (%): 6.399417781588339
Revenue growth (%): -6.857086408045143
Rule of 40 score: -0.4576686264568046
Financial ratios for BELYS.BR — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -17566666.666666668
Buffett classification: The Gruesome
Stock price: 0.6666666666666667
Shares outstanding: 35943396
Book value: 99481250.00000003
P/B ratio: 0.24087216435257897
Market cap (USD): 23962264.000000004
Debt to equity: 1.7431048564427964
Current ratio: 1.784878351831019
Quick ratio: 0.9519284047215272
Buyback yield (%): 0
Retained earnings: -199705208.33333334
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BELYS.BR — annual report dated 2024-12-31
Total revenue: 292063541.6666667
Gross profit: 177644791.6666667
Operating income: 22985416.666666668
Net income: 11013541.666666668
Capital expenditures: 9672916.666666668
Operating cash flow: 41804166.66666667
Depreciation & amortization: 20397916.666666668
Net tangible assets: -17566666.666666668
Owner earnings: 21738541.666666668
Return on net tangible assets (%): -123.74881404174573
Capex to operating income (%): 42.08284238194508
Buffett classification: The Good
Stock price: 0.6666666666666667
P/E ratio: 2.1757092064693087
Shares outstanding: 35943396
Book value: 99481250.00000003
P/B ratio: 0.24087216435257897
Market cap (USD): 23962264.000000004
Debt to equity: 1.7431048564427964
Current ratio: 1.784878351831019
Quick ratio: 0.9519284047215272
Effective tax rate (%): 18.045112781954884
Interest coverage ratio: 1.2008707482993197
COGS to revenue (%): 39.175978400818884
SG&A to revenue (%): 6.97693495636295
Free cash flow (dilution-adjusted): 31169791.666666668
Buyback yield (%): 0
Retained earnings: -199705208.33333334
Inventory turnover: 2.214199322689889
Receivables turnover: 16.984552944027136
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.463420808370602
FCF margin (%): 10.672263812455194
Revenue growth (%): -12.648233904252976
Rule of 40 score: -1.975970091797782
Financial ratios for BELYS.BR — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -24765882.352941178
Buffett classification: The Gruesome
Stock price: 0.8235294117647058
Shares outstanding: 35943396
Book value: 96295294.11764705
P/B ratio: 0.3073924228170701
Market cap (USD): 29600443.76470588
Debt to equity: 1.921858010286985
Current ratio: 1.6305808780062847
Quick ratio: 0.9019165551787437
Buyback yield (%): 0
Retained earnings: -225669411.7647059
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEN.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.917293233082707
Shares outstanding: 563866856
Market cap (USD): 3336565531.368421
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEN.AX — annual report dated 2022-06-30
Total revenue: 1153862068.9655173
Net income: 336620689.6551724
Capital expenditures: 8000000
Operating cash flow: -2241310344.827586
Depreciation & amortization: 68413793.10344827
Net tangible assets: 3381793103.448276
Owner earnings: 397034482.7586207
Return on net tangible assets (%): 11.740354025613833
Buffett classification: The Gruesome
Stock price: 4.958620689655173
P/E ratio: 8.30609033935669
Shares outstanding: 563866856
Book value: 4628896551.724136
P/B ratio: 0.6040320467587422
Market cap (USD): 2796001858.372414
Debt to equity: 1.9687271860427011
Effective tax rate (%): 30.41060735671514
COGS to revenue (%): 0
SG&A to revenue (%): 3.2992648377263762
Free cash flow (dilution-adjusted): -2251310344.827586
Buyback yield (%): 0.2145921320486057
Retained earnings: 956206896.5517242
Receivables turnover: 5.503618421052631
Capitalized R&D asset: 0
FCF margin (%): -195.11087203394894
Rule of 40 score: -195.11087203394894
Financial ratios for BEN.AX — annual report dated 2023-06-30
Total revenue: 1256092715.2317882
Net income: 329139072.8476821
Capital expenditures: 20198675.496688742
Operating cash flow: 3777682119.205298
Depreciation & amortization: 68079470.1986755
Net tangible assets: 3317086092.715232
Owner earnings: 377019867.5496689
Return on net tangible assets (%): 11.365995847308737
Buffett classification: The Gruesome
Stock price: 4.788079470198676
P/E ratio: 8.202731124507043
Shares outstanding: 563866856
Book value: 4536887417.218536
P/B ratio: 0.5950862494168488
Market cap (USD): 2699839317.1390734
Debt to equity: 1.945056709533335
Effective tax rate (%): 31.42935982339956
COGS to revenue (%): 0
SG&A to revenue (%): 4.702905045605525
Free cash flow (dilution-adjusted): 3757417218.5430465
Buyback yield (%): 0
Retained earnings: 1037947019.8675497
Receivables turnover: 3.6929517133956384
Capitalized R&D asset: 0
FCF margin (%): 299.13534032793797
Revenue growth (%): 8.859867138012836
Rule of 40 score: 307.9952074659508
Financial ratios for BEN.AX — annual report dated 2024-06-30
Total revenue: 1344400000
Net income: 363333333.3333333
Capital expenditures: 18133333.333333332
Operating cash flow: -3944333333.3333335
Depreciation & amortization: 74533333.33333333
Net tangible assets: 3416133333.3333335
Owner earnings: 419733333.3333333
Return on net tangible assets (%): 12.286795987666366
Buffett classification: The Gruesome
Stock price: 6.88
P/E ratio: 10.677258631045872
Shares outstanding: 563866856
Book value: 4689333333.333336
P/B ratio: 0.827282620688086
Market cap (USD): 3879403969.2799997
Debt to equity: 1.5280210406596524
Effective tax rate (%): 31.635725037631712
COGS to revenue (%): 0
SG&A to revenue (%): 5.38034315183973
Free cash flow (dilution-adjusted): -3962466666.6666665
Buyback yield (%): 5.712217695161248
Retained earnings: 1174666666.6666667
Receivables turnover: 4.219711236660389
Capitalized R&D asset: 0
FCF margin (%): -294.7386690469106
Revenue growth (%): 7.030315811672899
Rule of 40 score: -287.7083532352377
Financial ratios for BEN.AX — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 3201180124.2236023
Buffett classification: The Gruesome
Stock price: 7.515527950310559
Shares outstanding: 563866856
Book value: 4405652173.913048
P/B ratio: 0.9618909866771923
Market cap (USD): 4237757116.521739
Debt to equity: 1.6362944269783293
Buyback yield (%): 0
Retained earnings: 1125341614.9068322
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEN.AX — annual report dated 2025-06-30
Total revenue: 1251568627.4509804
Net income: -63464052.2875817
Capital expenditures: 11960784.31372549
Operating cash flow: 1109215686.2745097
Depreciation & amortization: 78758169.93464053
Net tangible assets: 3424967320.261438
Owner earnings: 3333333.3333333395
Buffett classification: The Gruesome
Stock price: 7.8431372549019605
Shares outstanding: 563866856
Book value: 4359673202.61438
P/B ratio: 1.014407488718648
Market cap (USD): 4422485145.098039
Debt to equity: 1.7047808944125449
Effective tax rate (%): 192.21272554605886
COGS to revenue (%): 0
SG&A to revenue (%): 5.603425766358557
Free cash flow (dilution-adjusted): 1097254901.9607842
Buyback yield (%): 0.8616100204572643
Retained earnings: 868104575.1633986
Receivables turnover: 3.197361830021707
Capitalized R&D asset: 0
FCF margin (%): 87.67037443208523
Revenue growth (%): -6.905041100046086
Rule of 40 score: 80.76533333203913
Financial ratios for BEN.AX — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 3424967320.261438
Buffett classification: The Gruesome
Stock price: 7.8431372549019605
Shares outstanding: 563866856
Book value: 4359673202.61438
P/B ratio: 1.014407488718648
Market cap (USD): 4422485145.098039
Debt to equity: 1.7047808944125449
Buyback yield (%): 0
Retained earnings: 868104575.1633986
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLOE.L — annual report dated 2021-12-31
Total revenue: 8262162.162162162
Gross profit: 312162.1621621622
Operating income: -6344594.594594595
Net income: -6463513.513513514
Capital expenditures: 8658108.108108109
Operating cash flow: -763513.5135135135
Depreciation & amortization: 3920270.2702702703
Net tangible assets: 36574324.324324325
Owner earnings: -11201351.351351352
Return on net tangible assets (%): -30.626270090522816
Buffett classification: The Gruesome
Stock price: 0.00013513513513513514
Shares outstanding: 1469379955
Book value: 36574324.324324325
P/B ratio: 0.00542907797893959
Market cap (USD): 198564.8587837838
Debt to equity: 0
Current ratio: 1.7044807044807047
Quick ratio: 0.5169645169645171
Interest coverage ratio: -53.96551724137931
COGS to revenue (%): 96.22178606476938
SG&A to revenue (%): 56.133464180569185
Free cash flow (dilution-adjusted): -11440540.54054054
Buyback yield (%): 0
Retained earnings: -29118918.91891892
Inventory turnover: 1.2830970556161396
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.34712728616294
FCF margin (%): -138.46908734052994
Rule of 40 score: -138.46908734052994
Financial ratios for BLOE.L — annual report dated 2022-12-31
Total revenue: 9954216.86746988
Gross profit: 2787951.807228916
Operating income: -2166265.060240964
Net income: -1937349.3975903615
Capital expenditures: 3289156.626506024
Operating cash flow: 1836144.5783132531
Depreciation & amortization: 2356626.5060240966
Net tangible assets: 32771084.3373494
Owner earnings: -2869879.518072289
Return on net tangible assets (%): -8.75735294117647
Buffett classification: The Gruesome
Stock price: 0.00012048192771084338
Shares outstanding: 1469379955
Book value: 32771084.3373494
P/B ratio: 0.0054021321874999995
Market cap (USD): 177033.7295180723
Debt to equity: 0
Current ratio: 1.6981850117096018
Quick ratio: 0.2956674473067914
Interest coverage ratio: -26.835820895522385
COGS to revenue (%): 71.9922536916001
SG&A to revenue (%): 36.79496489954006
Free cash flow (dilution-adjusted): -2744578.3132530125
Buyback yield (%): 0
Retained earnings: -19697590.361445785
Inventory turnover: 1.2414944687956584
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -6.610294117647059
FCF margin (%): -27.572016460905353
Revenue growth (%): 20.47956300176172
Rule of 40 score: -7.092453459143634
Financial ratios for BLOE.L — annual report dated 2023-12-31
Total revenue: 10589873.41772152
Gross profit: 4007594.9367088606
Operating income: 120253.16455696202
Net income: -2801265.82278481
Capital expenditures: 3911392.405063291
Operating cash flow: 1984810.1265822784
Depreciation & amortization: 1739240.5063291139
Net tangible assets: 32475949.367088605
Owner earnings: -4973417.721518987
Return on net tangible assets (%): -15.314156532584972
Capex to operating income (%): 3252.6315789473683
Buffett classification: The Gruesome
Stock price: 0.00012658227848101267
Shares outstanding: 1469379955
Book value: 32539240.506329115
P/B ratio: 0.005716097234108769
Market cap (USD): 185997.46265822786
Debt to equity: 0.07780284758422158
Current ratio: 1.4241071428571428
Quick ratio: 0.39567669172932324
COGS to revenue (%): 62.15634711929238
SG&A to revenue (%): 31.759502749223046
Free cash flow (dilution-adjusted): -2450632.911392405
Buyback yield (%): 0
Retained earnings: -23277215.189873416
Inventory turnover: 1.1880283299063286
Receivables turnover: 35.90557939914163
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3695635260250525
FCF margin (%): -23.14128615825962
Revenue growth (%): 6.3858017030847245
Rule of 40 score: -16.755484455174898
Financial ratios for BLOE.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 31306250
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 1469379955
Book value: 31641250
P/B ratio: 0.005804843183344527
Market cap (USD): 183672.494375
Debt to equity: 0.0790107849721487
Current ratio: 2.875115207373272
Quick ratio: 0.8940092165898618
Buyback yield (%): 0
Retained earnings: -23747500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BLOE.L — annual report dated 2024-12-31
Total revenue: 9416250
Gross profit: 3473750
Operating income: -218750
Net income: -761250
Capital expenditures: 828750
Operating cash flow: 1746250
Depreciation & amortization: 1545000
Net tangible assets: 31306250
Owner earnings: -45000
Return on net tangible assets (%): -0.14374126572170096
Buffett classification: The Gruesome
Stock price: 0.000125
Shares outstanding: 1469379955
Book value: 31641250
P/B ratio: 0.005804843183344527
Market cap (USD): 183672.494375
Debt to equity: 0.0790107849721487
Current ratio: 2.875115207373272
Quick ratio: 0.8940092165898618
Interest coverage ratio: -0.7575757575757576
COGS to revenue (%): 63.10898712332404
SG&A to revenue (%): 14.894464356829948
Free cash flow (dilution-adjusted): 435000
Buyback yield (%): 0
Retained earnings: -23747500
Inventory turnover: 1.10583856710863
Receivables turnover: 13.123693379790941
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.6407205360084941
FCF margin (%): 4.619673436877738
Revenue growth (%): -11.082506574229024
Rule of 40 score: -6.462833137351286
Financial ratios for BLOE.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 33778082.19178082
Buffett classification: The Gruesome
Stock price: 0.00013698630136986303
Shares outstanding: 1469379955
Book value: 34350684.93150686
P/B ratio: 0.005859706312809059
Market cap (USD): 201284.92534246578
Debt to equity: 0.07975753708725473
Current ratio: 1.6173938854259424
Quick ratio: 0.4722469575541705
Buyback yield (%): 0
Retained earnings: -26900000
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNZ.AX — annual report dated 2022-04-30
Total revenue: 0
Operating income: -15868427.34375
Net income: -9781689.84375
Capital expenditures: 125596.875
Operating cash flow: -15718660.9375
Net tangible assets: 2745382.8125
Owner earnings: -9907286.71875
Return on net tangible assets (%): -360.87086557259494
Buffett classification: The Gruesome
Stock price: 0.6737588652482269
Shares outstanding: 333857248
Book value: 2745382.8125
P/B ratio: 81.9336667889101
Market cap (USD): 224939280.56737587
Debt to equity: 0
Current ratio: 1.6631531373978452
Quick ratio: 1.6631531373978452
Free cash flow (dilution-adjusted): -15848159.375
Buyback yield (%): 0
Retained earnings: -22655104.6875
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -578.00417746842
Rule of 40 score: 0
Financial ratios for BNZ.AX — annual report dated 2023-04-30
Total revenue: 0
Operating income: -5053434.558823529
Net income: -3512472.058823529
Capital expenditures: 243117.64705882352
Operating cash flow: -5411861.764705882
Net tangible assets: 6445423.529411764
Owner earnings: -3755589.705882353
Return on net tangible assets (%): -58.267539576644445
Buffett classification: The Gruesome
Stock price: 0.24503311258278146
Shares outstanding: 333857248
Book value: 6445423.529411765
P/B ratio: 12.692118719966807
Market cap (USD): 81806080.63576159
Debt to equity: 0
Current ratio: 2.533919189457375
Quick ratio: 2.533919189457375
Free cash flow (dilution-adjusted): -5654979.411764706
Buyback yield (%): 0
Retained earnings: -22691198.529411763
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -78.40345224427364
Rule of 40 score: 0
Financial ratios for BNZ.AX — annual report dated 2024-04-30
Total revenue: 0
Gross profit: 0
Operating income: -5211315.328467153
Net income: -2937577.3722627736
Capital expenditures: 985401.4598540146
Operating cash flow: -5436408.759124087
Depreciation & amortization: 0
Net tangible assets: 5297297.810218978
Owner earnings: -3922978.8321167883
Return on net tangible assets (%): -74.05622588461988
Buffett classification: The Gruesome
Stock price: 0.10526315789473684
Shares outstanding: 333857248
Book value: 5297297.810218978
P/B ratio: 6.634112234115376
Market cap (USD): 35142868.21052632
Debt to equity: 0
Current ratio: 10.238495544752173
Quick ratio: 10.238495544752173
Interest coverage ratio: -1576.3969971296092
Free cash flow (dilution-adjusted): -6738663.503649634
Buyback yield (%): 0
Retained earnings: -23589938.686131384
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -98.37686147103233
Rule of 40 score: 0
Financial ratios for BNZ.AX — quarterly report dated 2024-10-31
Gross profit: 0
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.17105263157894737
Shares outstanding: 333857248
Market cap (USD): 57107160.84210526
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BNZ.AX — quarterly report dated 2025-01-31
Total revenue: 0
Gross profit: 0
Operating income: -1414652.4137931035
Net income: -1443566.8965517243
Capital expenditures: 306392.4137931035
Operating cash flow: -835502.0689655172
Depreciation & amortization: 0
Net tangible assets: 12926039.310344828
Owner earnings: -1749959.3103448278
Return on net tangible assets (%): -13.538248401769282
Buffett classification: The Gruesome
Stock price: 0.24223602484472048
Shares outstanding: 333857248
Book value: 12926039.310344828
P/B ratio: 6.256537728180603
Market cap (USD): 80872252.62111801
Debt to equity: 0
Current ratio: 4.909591951509093
Quick ratio: 4.909591951509093
Interest coverage ratio: -1415.6287094547963
Free cash flow (dilution-adjusted): -1645942.7586206896
Buyback yield (%): 0
Retained earnings: -24332755.862068966
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.94420634061467
Rule of 40 score: 0
Financial ratios for BNZ.AX — annual report dated 2025-04-30
Total revenue: 0
Gross profit: -6837.68115942029
Operating income: -5409160.869565218
Net income: -5437818.115942029
Capital expenditures: 692646.3768115942
Operating cash flow: -2379047.1014492754
Depreciation & amortization: 6837.68115942029
Net tangible assets: 16590126.811594205
Owner earnings: -6123626.811594203
Return on net tangible assets (%): -36.91127187354972
Buffett classification: The Gruesome
Stock price: 0.2484076433121019
Shares outstanding: 333857248
Book value: 16590126.811594205
P/B ratio: 4.9989185206459945
Market cap (USD): 82932692.17834395
Debt to equity: 0.006691468974365973
Current ratio: 8.347822188557641
Quick ratio: 8.347822188557641
Interest coverage ratio: -361.4313659032586
Free cash flow (dilution-adjusted): -4614630.434782609
Buyback yield (%): 0
Retained earnings: -28855976.086956523
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -30.771465053749587
Rule of 40 score: 0
Financial ratios for BNZ.AX — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -3230774.6376811597
Net income: -3288950.0000000005
Capital expenditures: 370712.3188405797
Operating cash flow: -1266623.9130434783
Net tangible assets: 16590126.811594205
Owner earnings: -3659662.31884058
Return on net tangible assets (%): -22.059278752968797
Buffett classification: The Gruesome
Stock price: 0.2484076433121019
Shares outstanding: 333857248
Book value: 16590126.811594205
P/B ratio: 4.9989185206459945
Market cap (USD): 82932692.17834395
Debt to equity: 0.006691468974365973
Current ratio: 8.347822188557641
Quick ratio: 8.347822188557641
Interest coverage ratio: -360.16390661604333
Free cash flow (dilution-adjusted): -2566868.8405797104
Buyback yield (%): 0
Retained earnings: -28855976.086956523
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.379129639000215
Rule of 40 score: 0
Financial ratios for BNZ.AX — quarterly report dated 2025-07-31
Total revenue: 0
Gross profit: -12263.76811594203
Operating income: -2692280.434782609
Net income: -2591015.2173913047
Capital expenditures: 87578.26086956523
Operating cash flow: -2142481.15942029
Depreciation & amortization: 12263.76811594203
Net tangible assets: 15451655.797101451
Owner earnings: -2666329.710144928
Return on net tangible assets (%): -17.255948133695163
Buffett classification: The Gruesome
Stock price: 0.41935483870967744
Shares outstanding: 333857248
Book value: 15451655.79710145
P/B ratio: 9.060818738491445
Market cap (USD): 140004652.3870968
Debt to equity: 0.006697936082550133
Current ratio: 4.958365007015783
Quick ratio: 4.958365007015783
Interest coverage ratio: -200.91645035691107
Free cash flow (dilution-adjusted): -2230059.4202898555
Buyback yield (%): 0
Retained earnings: -31446991.304347828
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -16.38023695381972
Rule of 40 score: 0
Financial ratios for BNZ.AX — quarterly report dated 2025-10-31
Total revenue: 0
Gross profit: -13433.57142857143
Operating income: -6704925.714285715
Net income: -5829647.142857144
Capital expenditures: 774596.4285714286
Operating cash flow: -5185172.857142857
Depreciation & amortization: 13433.57142857143
Net tangible assets: 27353417.142857146
Owner earnings: -6590810
Return on net tangible assets (%): -24.095015133131444
Buffett classification: The Gruesome
Stock price: 1.006578947368421
Shares outstanding: 333857248
Book value: 27353417.142857146
P/B ratio: 12.28561958120513
Market cap (USD): 336053677.2631579
Debt to equity: 0.00324545504682831
Current ratio: 6.287769858337057
Quick ratio: 6.287769858337057
Interest coverage ratio: -846.0474087426768
Free cash flow (dilution-adjusted): -5959769.285714286
Buyback yield (%): 0
Retained earnings: -36827395.71428572
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -23.678055793906864
Rule of 40 score: 0
Financial ratios for CEPS.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.007027027027027026
Shares outstanding: 21000000
Market cap (USD): 147567.56756756754
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEPS.L — annual report dated 2022-12-31
Total revenue: 31866265.060240965
Gross profit: 13145783.132530121
Operating income: 2580722.8915662654
Net income: 1296385.5421686748
Capital expenditures: 144578.31325301205
Operating cash flow: 2010843.373493976
Depreciation & amortization: 866265.0602409639
Net tangible assets: -12213253.012048194
Owner earnings: 2018072.2891566264
Return on net tangible assets (%): -16.52362631942389
Capex to operating income (%): 5.602240896358543
Buffett classification: The Great
Stock price: 0.004819277108433735
P/E ratio: 0.07806691449814127
Shares outstanding: 21000000
Book value: 5439759.036144577
P/B ratio: 0.018604651162790704
Market cap (USD): 101204.81927710844
Debt to equity: 2.588925802879292
Current ratio: 1.1304215492314715
Quick ratio: 0.8050525034241365
Effective tax rate (%): 20.059435364041605
Interest coverage ratio: 2.991620111731844
COGS to revenue (%): 58.747022571741844
SG&A to revenue (%): 32.568339067639606
Free cash flow (dilution-adjusted): 1775903.6144578315
Buyback yield (%): 0
Retained earnings: -9067469.879518073
Inventory turnover: 7.267539756782041
Receivables turnover: 8.45286033876638
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.327759197324417
FCF margin (%): 5.572989527014254
Rule of 40 score: 5.572989527014254
Financial ratios for CEPS.L — annual report dated 2023-12-31
Total revenue: 37563291.1392405
Gross profit: 15807594.93670886
Operating income: 2906329.1139240507
Net income: 1549367.0886075948
Capital expenditures: 772151.8987341772
Operating cash flow: 3575949.3670886075
Depreciation & amortization: 1039240.5063291139
Net tangible assets: -11922784.810126582
Owner earnings: 1816455.6962025317
Return on net tangible assets (%): -15.235162968467991
Capex to operating income (%): 26.56794425087108
Buffett classification: The Good
Stock price: 0.0035443037974683548
P/E ratio: 0.04803921568627452
Shares outstanding: 21000000
Book value: 7079746.8354430385
P/B ratio: 0.01051314142678348
Market cap (USD): 74430.37974683545
Debt to equity: 2.0091185410334345
Current ratio: 1.0559014267185474
Quick ratio: 0.7461738002594034
Effective tax rate (%): 31.658291457286435
Interest coverage ratio: 2.9740932642487046
COGS to revenue (%): 57.91743892165122
SG&A to revenue (%): 33.33445661331086
Free cash flow (dilution-adjusted): 2702531.64556962
Buyback yield (%): 0
Retained earnings: -8773417.721518988
Inventory turnover: 7.197236180904522
Receivables turnover: 7.75208986415883
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.271034253408713
FCF margin (%): 7.194608256107836
Revenue growth (%): 17.8779222109328
Rule of 40 score: 25.072530467040636
Financial ratios for CEPS.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -10982500
Buffett classification: The Gruesome
Stock price: 0.0029999999999999996
Shares outstanding: 21000000
Book value: 6207500
P/B ratio: 0.010149013290374546
Market cap (USD): 62999.99999999999
Debt to equity: 2.144784534836891
Current ratio: 0.8046950369814557
Quick ratio: 0.5532211383856791
Buyback yield (%): 0
Retained earnings: 3442500
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CEPS.L — annual report dated 2024-12-31
Total revenue: 12708750
Gross profit: 4961250
Operating income: 52500
Net income: 1622500
Capital expenditures: 177500
Operating cash flow: 4431250
Depreciation & amortization: 1127500
Net tangible assets: -10982500
Owner earnings: 2572500
Return on net tangible assets (%): -23.42362849988618
Capex to operating income (%): 338.0952380952381
Buffett classification: The Gruesome
Stock price: 0.0029999999999999996
P/E ratio: 0.038828967642526954
Shares outstanding: 21000000
Book value: 6207500
P/B ratio: 0.010149013290374546
Market cap (USD): 62999.99999999999
Debt to equity: 2.144784534836891
Current ratio: 0.8046950369814557
Quick ratio: 0.5532211383856791
Interest coverage ratio: 0.08955223880597014
COGS to revenue (%): 60.96193567424019
SG&A to revenue (%): 38.62496311596341
Free cash flow (dilution-adjusted): 4213750
Buyback yield (%): 0
Retained earnings: 3442500
Inventory turnover: 2.6419437340153453
Receivables turnover: 2.696101829753381
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3367543296985247
FCF margin (%): 33.156289957706306
Revenue growth (%): -66.16710193765796
Rule of 40 score: -33.010811979951654